Please try another search
For the three months ended 31 March 2022, Kainos Medicine Inc revenues decreased 96% to W3.7M. Net loss increased 9% to W3.8B. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Basic Earnings per Share excluding Extraordinary Items decreased from -W33.22 to -W34.44.
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 3.67 | 1258 | 151.66 | 160.62 |
Gross Profit | 2.57 | 1255.83 | ||
Operating Income | -3877.9 | -1432.66 | -4260.88 | -1997.55 |
Net Income | -3801.66 | -2766.73 | -5059.57 | -4894.67 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 39471.8 | 41956.76 | 31127.35 | 32503.58 |
Total Liabilities | 30706.33 | 29853.23 | 29330.56 | 26935.53 |
Total Equity | 8765.47 | 12103.53 | 1796.79 | 5568.05 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -1747.99 | -9195.21 | -6859.33 | -4807.84 |
Cash From Investing Activities | -3671.76 | -5753.49 | 3133.84 | 1106.5 |
Cash From Financing Activities | 809.54 | 14666.52 | 1958.9 | 941.21 |
Net Change in Cash | -4677.39 | 1279.08 | -576.48 | -2500.22 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review